Interpace Biosciences Inc organizacji Beta

Jaka jest wartość Beta organizacji Interpace Biosciences Inc?

Wartość Beta organizacji Interpace Biosciences Inc to 0.00

Jaka jest definicja Beta?



BETA wskazuje, czy akcje są bardziej lub mniej zmienne niż rynek jako całość. Beta mniejsza niż 1 wskazuje, że akcje są mniej zmienne niż rynek, a beta więcej niż 1 wskazuje, że akcje są bardziej niestabilne. Zmienność jest mierzona jako fluktuacja ceny wokół średniej.

Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.

Beta firm w Health Care sektor na NASDAQ w porównaniu do Interpace Biosciences Inc

Czym się zajmuję organizacja Interpace Biosciences Inc?

advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.

Firmy z beta podobne do Interpace Biosciences Inc